Biocorrx Pharmaceuticals, Inc.
Anaheim, CA
- UEI
- N9U2KLZRWGH3
- CAGE
- 8NSN9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2390 E Orangewood Ave # 570, Anaheim, CA 92806, USA
- Website
- biocorrx.com
- Founded
- 2016
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with… | National Institute on Drug Abuse (NIH) | $19,798,933 |
Quick answers
Is Biocorrx Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Biocorrx Pharmaceuticals, Inc.'s SAM.gov registration is active through July 29, 2027.
What is Biocorrx Pharmaceuticals, Inc.'s most recent federal award?
Biocorrx Pharmaceuticals, Inc.'s most recent federal grant award is Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with… (U01DA059994), from National Institute on Drug Abuse (NIH), on March 1, 2024.
On GovTribe
See Biocorrx Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors